Pharmacological exposure to ribavirin: A key player in the complex network of factors implicated in virological response and anaemia in hepatitis C treatment-Reference-Cited by-同舟云学术

Pharmacological exposure to ribavirin: A key player in the complex network of factors implicated in virological response and anaemia in hepatitis C treatment

Published:2011-11 Issue:11 Volume:43 Page:850-855
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Loustaud-Ratti Véronique,Carrier Paul,Rousseau Annick,Maynard Marianne,Babany Gérard,Alain Sophie,Trépo Christian,De Ledinghen Victor,Bourlière Marc,Pol Stanislas,Di Martino Vincent,Zarski Jean-Pierre,Pinta Alexandrina,Sautereau Denis,Marquet Pierre

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference67 articles.

1. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

2. Pegylated interferon monotherapy for chronic hepatitis C;Heathcote;Semin Liver Dis,2004

3. Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin;Bronowicki;Gastroenterology,2006

4. Telaprevir and peginterferon with or without ribavirin for chronic HCV infection;Hezode;N Engl J Med,2009

5. Ribavirin dosing in chronic hepatitis C: application of population pharmacokinetic–pharmacodynamic models;Jen;Clin Pharmacol Ther,2002

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of novel C-nucleoside analogues bearing an anomeric cyano and a 1,2,3-triazole nucleobase as potential antiviral agents;Organic & Biomolecular Chemistry;2022

2. Efficiency and Safety of an Early Dose Adjustment of Ribavirin in Patients Infected With Hepatitis C Underexposed to the Drug and Treated With Peginterferon Ribavirin;Therapeutic Drug Monitoring;2016-12

3. Synthesis and Evaluation of Bile Acid–Ribavirin Conjugates as Prodrugs to Target the Liver;Journal of Pharmaceutical Sciences;2015-09

4. Patients treated with first-generation HCV protease inhibitors exhibit high ribavirin concentrations;The Journal of Clinical Pharmacology;2015-02-04

5. Ribavirin concentration determines treatment success of first-generation DAA-based chronic HCV therapy;Antiviral Therapy;2015